Nam augue velit, fermentum sed erat non, efficitur interdum lectus. Donec hendrerit lorem a dui euismod tempus. Vivamus auctor blandit tellus et interdum.
Contact Us
Have a question
61 3 8376 6284
Address
PO Box 16122 Collins Street West Victoria 8007 Australia
Email us
support24-7@gmail.com
HEART FAILURE NEED
The Need – Acute Decompensated Heart Failure (ADHF)
1
Heart failure is when the heart fails to pump sufficient oxygenated blood necessary for the functioning of bodily tissues and organs, including the heart’s own needs.
2
Acute Decompensated Heart Failure (ADHF) is a life-threatening acute presentation
of heart failure, and is the cause of up to 2 million US emergency hospital
admissions annually. Patients present with congestion & fluid retention, shortness of
breath and lower limb swelling. For many patients, emergency hospital admission is
required. Poor treatment outcomes are common with 60% of hospitalized patients
discharged with persistent congestion, leading to short-term re-hospitalization, poor
quality of life, and high mortality.
3
There is a clear need for more effective acute treatment options for patients with
ADHF and potential for longer term therapy to reduce re-admissions, improve quality
of life and reduce the unacceptable early mortality rate.
4
Over 1M patients per year in the US are estimated to be indicated for the QHeart
Medical TARR™ device during acute in-hospital use, representing a significant
revenue opportunity for the TARR™ device.
QHeart Medical Pty Ltd is an Australian privately owned, clinical stage MedTech company exploring the clinical utility of a novel “pumpless” heart assist device to address unresolved clinical consequences of heart failure, focused initially on the treatment of acute decompensated heart failure (ADHF).